About 3,000 vaginal mesh lawsuits filed against C.R. Bard have been settled, according to a recent SEC filing, which suggests that the manufacturer is starting to resolve large groups of…
The medical device manufacturer Covidien has announced a settlement of more than 11,000 transvaginal mesh lawsuits.
A large wave of Bard Avaulta lawsuits will be prepared for trial in courts throughout the country, as the litigation continues to grow.
Covidien is taking a $180 million charge for legal costs of its ties with Bard Avaulta vaginal mesh products.
A federal judge has ordered a census of all Bard Avaulta vaginal mesh cases pending throughout the country.
The last in a series of bellwether trials involving Bard Avaulta vaginal mesh has been delayed until next month.
The last Bard Avaulta bellwether trial has been delayed until early December.
Vaginal mesh bellwether trials are scheduled well into next year and could determine the outcome of ongoing settlement negotiations.
A federal judge has rejected an attempt to overturn a $2M Bard Avaulta verdict.
The first bellwether Ethicon vaginal mesh trials will go before a jury in February involving Gynecare TVT mesh.
